Cowen Inc’s Albany Molecular Research Inc AMRI Stock Holding History

Cowen Inc’s Portfolio AMRI Stock Details AMRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-35,000	Closed	-$760K	–	395
2017 Q2	$760K	Buy	+35,000	New	+$635K	0.04%	191
2015 Q3	–	Sell	-13,958	Closed	-$282K	–	498
2015 Q2	$282K	Hold	13,958	–	–	0.02%	296
2015 Q1	$246K	Buy	+13,958	New	+$238K	0.02%	279

Other funds holding AMRI

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Cowen Inc's AMRI Position: Q3 2017 in Review

Cowen Inc sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 35,000 shares — an estimated $760K sold.

Cowen Inc first reported a position in AMRI in Q1 2015 and held it in 3 quarters. The position peaked at $760K in Q2 2017. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

Cowen Inc reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
Cowen Inc sold 35,000 Albany Molecular Research Inc shares in Q3 2017, an estimated $760K.
Cowen Inc first reported a position in Albany Molecular Research Inc in Q1 2015 and held it in 3 quarters.
Cowen Inc's Albany Molecular Research Inc position peaked at $760K in Q2 2017.
2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on Cowen Inc's 13F filing for Q3 2017, filed 14 Nov 2017.